Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Zapages
    Member
    • Oct 2012
    • 98

    #1

    Cuffdiff Question with FPKM of one sample being 0

    Hi Everyone,

    I have question in regards to cuffdiff. I have the following data in tissue 1 vs tissue 2.

    Code:
    Sample A: 0 Sample B: 20.292 Log2 Change(fold change): 1.79769e+308
    My understanding for the fold change to be 1.79769e+308 is due to the cufflinks/cuffdiff normalization method goes to close to infinite due to sample A having 0 FPKM value

    But what other explanation could there be for this?

    Many thanks in advance.
  • kmcarr
    Senior Member
    • May 2008
    • 1181

    #2
    This is just an artifact of the numeric type which cufflinks uses to store the Log2FC value. Apparently it is storing this value as a double because the largest possible value for that type is 1.79769e+308.
    Last edited by kmcarr; 02-03-2016, 05:53 AM.

    Comment

    • Zapages
      Member
      • Oct 2012
      • 98

      #3
      That is interesting, but should we take this FPKM value for this number as something to be highly expressed or should we take a look at isoforms and see the confidence intervals to consider its true expression.

      I just found two interesting discussions about it, where they state the FPKM should not be taken for the face value and the confidence intervals seriously consider for gene to be expressed.

      https://www.biostars.org/p/72486/ , https://biostar.usegalaxy.org/p/5022/ , and https://biostar.usegalaxy.org/p/4940/


      I was wondering what is your opinion about this.

      Thank you again.
      Last edited by Zapages; 02-03-2016, 10:15 AM.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      42 views
      0 reactions
      Last Post SEQadmin2  
      Working...